uridine has been researched along with Brain Damage, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrew, MJ; Baker, B; Braddick, O; Laler, K; Montague-Johnson, C; Parr, JR; Sullivan, PB; Williams, N | 1 |
| Harkness, RA; Lund, RJ | 1 |
1 trial(s) available for uridine and Brain Damage, Chronic
| Article | Year |
|---|---|
Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment, and children with suspected or confirmed cerebral palsy.
Topics: Birth Injuries; Brain Damage, Chronic; Cerebral Palsy; Choline; Docosahexaenoic Acids; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Neuronal Plasticity; Nootropic Agents; Risk Factors; Uridine; Vision, Ocular | 2015 |
1 other study(ies) available for uridine and Brain Damage, Chronic
| Article | Year |
|---|---|
Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.
Topics: Adult; Asphyxia Neonatorum; Brain Damage, Chronic; Female; Fetal Hypoxia; Humans; Hypoxanthines; Infant, Newborn; Inosine; Postmortem Changes; Pregnancy; Prognosis; Uric Acid; Uridine; Xanthines | 1983 |